Key Takeaways
- NovaBay Pharmaceuticals rallied nearly 19% following its announcement to transform into Stablecoin Development Corporation
- The firm will transition its ticker symbol from NBY to SDEV beginning April 3
- The company currently possesses 2.06 billion SKY tokens — representing approximately 8.8% of circulating supply — valued at roughly $150 million
- Tether Investments and Framework Ventures participated in a $134 million funding round that enabled this strategic transformation
- Monday’s rally notwithstanding, shares are still down over 95% on a year-to-date basis
NovaBay Pharmaceuticals witnessed its shares climb nearly 19% Monday following the disclosure of a dramatic strategic transformation from eye care biotechnology toward the stablecoin sector.
NovaBay Pharmaceuticals, Inc., NBY
The organization announced intentions to rename itself Stablecoin Development Corporation. The ticker symbol will transition from NBY to SDEV, officially becoming effective April 3.
CEO Michael Kazley characterized the transformation as a high-conviction wager on digital financial infrastructure. “The name change to Stablecoin Development Corporation reflects our conviction that stablecoins represent the most compelling structural opportunity in digital finance,” he stated in the announcement.
This strategic direction isn’t completely unprecedented. In January, NovaBay submitted documentation with the SEC detailing its vision to function as an “on-chain holding company framework focused on long-duration participation in protocol-level digital asset ecosystems.”
NBY shares climbed 19% to approximately $1.38–$1.40 following the announcement. However, shares remain down over 95% year to date, meaning Monday’s surge occurred from a significantly depressed baseline.
SKY Token Position Forms Strategic Foundation
The cornerstone of NovaBay’s transformed business model centers on its substantial stake in SKY, the governance token powering the Sky protocol — the rebranded MakerDAO platform responsible for issuing the USDS stablecoin.
As reported on March 16, the organization controls approximately 2.06 billion SKY tokens. This holding constitutes roughly 8.8% of total token circulation, with a market value approaching $150 million. SKY currently trades at $0.073 per CoinGecko data, reflecting a 15% year-to-date gain despite broader cryptocurrency market weakness.
This position was established utilizing capital from a $134 million private financing completed in January. Prominent participants in that funding round included Framework Ventures, Tether Investments, and the Sky Frontier Foundation.
Staking Revenue and Strategic Roadmap
NovaBay’s token staking operations have already produced 26.6 million SKY tokens in aggregate rewards. Management indicated plans to pursue additional SKY token acquisitions through open market purchases.
SKY currently stands as the sole digital asset authorized within the company’s operational and risk governance structure. Nevertheless, NovaBay has identified yield-generating stablecoins as a strategic priority for future expansion.
The firm characterized these financial instruments as “productive financial assets that unlock new primitives for savings, treasury management, and capital formation.”
NovaBay was established in 2000 in California and devoted more than twenty years to eye care biotechnology research before executing this strategic pivot.
The transformation arrives as stablecoin regulatory frameworks advance in Washington. Legislators recently achieved an “agreement in principle” regarding stablecoin yield treatment within comprehensive crypto market structure legislation — representing progress toward Senate Banking Committee regulatory measures.
The company’s operational thesis revolves around maintaining protocol-aligned digital asset positions for extended timeframes to capture what it describes as “protocol-level economic activity.”
Aggregate staking rewards have reached 26.6 million SKY tokens, with ongoing initiatives aimed at expanding the position substantially.


